However, because both medications impact your digestive system in different ways, there are specific considerations regarding timing, side effect management, and blood sugar monitoring
To maintain progress achieved through GLP-1 agonist therapy, continuous dedication to lifestyle interventions is necessary rather than just an initial attempt at improvement
Segn ha informado la compaa, en SURMOUNT-MAINTAIN , tanto la dosis mxima tolerada (DMT) de tirzepatida como la mnima de 5 mg alcanzaron los objetivos primarios y todos los objetivos clave secundarios , demostrando que es posible el mantenimiento de la prdida de peso despus de 60 semanas de tratamiento inicial con tirzepatida DMT
Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomised controlled trials
This side effect deserves special attention